Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 7 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT01620489Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedNCT01618162Phase 3Results posted
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCompletedNCT01617434Phase 3Results posted
• Weight Loss With Exenatide TreatmentCompletedNCT01590433Phase 4Results posted
• Acute Effect of Exenatide on Brain Glucose MetabolismCompletedNCT01588418Phase 4Results posted
• A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01584232Phase 3Results posted
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCompletedNCT01572740Phase 3Results posted
• Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRICompletedNCT01562678Phase 4Results posted
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01558271Phase 3Results posted
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaCompletedNCT01557166Phase 3Results posted
• Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 DiabetesCompletedNCT01554618Phase 3Results posted
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCompletedNCT01541215Phase 3Results posted
• A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual SyringeCompletedNCT01524770Phase 1Results posted
• FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)CompletedNCT01524705Phase 4Results posted
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCompletedNCT01512108Phase 3Results posted
• Adding Liraglutide to High Dose Insulin: Breaking the CycleCompletedNCT01505673Phase 4Results posted
• Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain TumorCompletedNCT01484873Phase 2Results posted
• Albiglutide Glucose Clamp Study in Subjects With Type 2 DiabetesCompletedNCT01475734Phase 2Results posted
• A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCompletedNCT01458210Phase 1Results posted
• Effects of Exenatide on Overweight Adolescents With Prader-Willi SyndromeCompletedNCT01444898Not applicableResults posted
• A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy ParticipantsCompletedNCT01436201Phase 1Results posted
• A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCompletedNCT01432938Phase 1Results posted
• Effect Of Exenatide Treatment on Liver Fat Content in Patients With DiabetesCompletedNCT01432405Phase 4Results posted
• A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)CompletedNCT01394952Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNCT01392573Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
• Changes in Bone Turnover With Exposure to a GLP-1 Receptor AgonistTerminatedNCT01381926Phase 4Results posted
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)CompletedNCT01373450Phase 1Results posted
• Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01364584Not applicableResults posted
• Pharmacokinetics/Pharmacodynamics of AlbiglutideCompletedNCT01357889Phase 2Results posted
• A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart FailureCompletedNCT01357850Phase 2Results posted
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3Results posted
• A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCompletedNCT01324388Phase 1Results posted
• A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.CompletedNCT01301092Phase 1Results posted
• Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
• A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy SubjectsCompletedNCT01297062Phase 1Results posted
• Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesCompletedNCT01272232Phase 3Results posted
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetesCompletedNCT01272219Phase 3Results posted
• Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaCompletedNCT01269047Phase 4Results posted
• New Onset Type 1 Diabetes: Role of ExenatideCompletedNCT01269034Phase 4Results posted
• A Pilot Clinical Trial of Exendin-4 in Alzheimer's DiseaseTerminatedNCT01255163Phase 2Results posted
• A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedNCT01253304Phase 1Results posted
• LY2189265 and Atorvastatin Interaction StudyCompletedNCT01250834Phase 1Results posted
• Exenatide in Extreme Pediatric ObesityCompletedNCT01237197Phase 2Results posted
• Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)CompletedNCT01234649Phase 3Results posted
• Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNCT01232946Not applicableResults posted
• A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTerminatedNCT01206101Phase 2Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
• The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and PrediabetesCompletedNCT01181986Phase 4Results posted
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCompletedNCT01179048Phase 3Results posted
• Exeantide in Type 2 Diabetes on InsulinCompletedNCT01154933Phase 2Results posted
• A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedNCT01149421Phase 2Results posted
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusCompletedNCT01144338Phase 3Results posted
• Impact of Exenatide on Sleep in Type 2 DiabetesCompletedNCT01136798Not applicableResults posted
• A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedNCT01128894Phase 3Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)CompletedNCT01126580Phase 3Results posted
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
• Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedNCT01098461Phase 2Results posted
• Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin GlargineCompletedNCT01089569Not applicableResults posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)CompletedNCT01075282Phase 3Results posted
• A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01064687Phase 3Results posted
• Effects of Exenatide on Hypothalamic ObesityCompletedNCT01061775Phase 1/2Results posted
• Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01029886Phase 3Results posted
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
• Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCompletedNCT01003184Phase 3Results posted
• A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
• Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) SurgeryTerminatedNCT00966654Phase 2Results posted
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesCompletedNCT00960661Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes MellitusCompletedNCT00935532Phase 3Results posted
• A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian SubjectsCompletedNCT00917267Phase 3Results posted
• A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly SuspensionCompletedNCT00894322Phase 1/2Results posted
• GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese ChildrenCompletedNCT00886626Phase 2Results posted
• Intravenous Exenatide (Byetta) During SurgeryCompletedNCT00882050Phase 1/2Results posted
• A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)CompletedNCT00877890Phase 3Results posted
• A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus MetforminCompletedNCT00870194Phase 4Results posted
• The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese SubjectsCompletedNCT00856609Phase 3Results posted
• Evaluation of Exenatide in Patients With Diabetic NeuropathyCompletedNCT00855439Not applicableResults posted
• Safety and Efficacy of Albiglutide in Type 2 DiabetesCompletedNCT00849056Phase 3Results posted
• Safety and Efficacy Study of Albiglutide in Type 2 DiabetesCompletedNCT00849017Phase 3Results posted
• Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese AdultsCompletedNCT00845507Phase 4Results posted
• Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell FunctionCompletedNCT00845182Phase 4Results posted
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesCompletedNCT00839527Phase 3Results posted
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesCompletedNCT00838916Phase 3Results posted
• Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesCompletedNCT00838903Phase 3Results posted
• Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart FailureTerminatedNCT00799435Phase 4Results posted
• Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCompletedNCT00791479Phase 2Results posted
• A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)CompletedNCT00782418Phase 1Results posted
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCompletedNCT00781937Phase 3Results posted
• Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassCompletedNCT00775684Not applicableResults posted
• Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusCompletedNCT00765817Phase 3Results posted
• Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminCompletedNCT00753896Phase 3Results posted
• Intravenous Exenatide in Coronary Intensive Care Unit (ICU) PatientsCompletedNCT00736229Phase 4Results posted
• A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCompletedNCT00734474Phase 2/3Results posted
• Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneCompletedNCT00729326Phase 4Results posted
• Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With MetforminTerminatedNCT00701935Phase 2Results posted

← Glucagon-Like Peptide-1 Receptor Agonists overview